| Name | ribulose-5-phosphate-3-epimerase-like 1 |
| Description | Predicted to enable D-ribulose-phosphate 3-epimerase activity and metal ion binding activity. Predicted to be involved in carbohydrate metabolic process and pentose-phosphate shunt, non-oxidative branch. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nVarious studies have demonstrated that coordinated transcriptional regulation by Egr family proteins and their NAB co‐regulators plays a critical role in controlling cellular differentiation and response to stress. In the heart, for instance, NAB1 is upregulated in heart failure and serves as an endogenous inhibitor of pathological cardiac hypertrophy by repressing Egr-dependent gene activation (for example, suppression of adrenergically induced and pressure overload‐induced hypertrophy), while in the peripheral nervous system, proper Schwann cell differentiation and myelination depend on the Egr2/NAB complex to promote cell cycle exit and activate myelin‑associated genes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistic studies have further detailed that NAB corepressors not only assist Egr2 in activating myelin gene expression but also in directly repressing genes whose continued expression would hinder myelination. For instance, repressive complexes formed by Egrs (including Egr3) and NAB proteins recruit chromatin remodeling factors such as CHD4 to silence target genes during developmental transitions in both neural and myeloid cells, thereby modulating inflammatory responses through downregulation of receptors like IFNGR1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn a more recent line of investigation, attention has turned to the RPEL1 gene, whose polymorphisms have been evaluated in Chinese systemic lupus erythematosus (SLE) patients. Unlike the extensively characterized NAB/Egr regulatory axis, RPEL1 remains less well defined functionally; however, its genetic variants (examined, for example, at rs4917385) may influence SLE susceptibility as well as modify clinical outcomes including glucocorticoid treatment efficacy, levels of anxiety and depression, and overall health‑related quality of life. These associations underscore a potential, albeit as yet poorly understood, role for RPEL1 in modulating immune and inflammatory pathways in autoimmunity and pave the way for further functional studies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Monika Buitrago, Kristina Lorenz, Alexander H Maass, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm1272"}], "href": "https://doi.org/10.1038/nm1272"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16025126"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16025126"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Nam Le, Rakesh Nagarajan, James Y T Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nab proteins are essential for peripheral nervous system myelination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Neurosci (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nn1490"}], "href": "https://doi.org/10.1038/nn1490"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16136673"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16136673"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Gennifer M Mager, Rebecca M Ward, Rajini Srinivasan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Active gene repression by the Egr2.NAB complex during peripheral nerve myelination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M803330200"}], "href": "https://doi.org/10.1074/jbc.M803330200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18456662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18456662"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Staci J Kearney, Christine Delgado, Emily M Eshleman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Type I IFNs downregulate myeloid cell IFN-γ receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1203510"}], "href": "https://doi.org/10.4049/jimmunol.1203510"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23935197"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23935197"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Zi-Ye Yan, Wan-Qin Hu, Qi-Qun Zong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Associations of RPEL1 and miR-1307 gene polymorphisms with disease susceptibility, glucocorticoid efficacy, anxiety, depression, and health-related quality of life in Chinese systemic lupus erythematosus patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lupus (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/09612033221131182"}], "href": "https://doi.org/10.1177/09612033221131182"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36194484"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36194484"}]}]}]}
|
| Proteins | RPEL1_HUMAN |
| NCBI Gene ID | 729020 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
RPEL1 has 1,580 functional associations with biological entities spanning 6 categories (functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 36 datasets.
Click the + buttons to view associations for RPEL1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of RPEL1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of RPEL1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of RPEL1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of RPEL1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of RPEL1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with RPEL1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by RPEL1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with RPEL1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with RPEL1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving RPEL1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving RPEL1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by RPEL1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by RPEL1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with RPEL1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of RPEL1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of RPEL1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of RPEL1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of RPEL1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for RPEL1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of RPEL1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of RPEL1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| KEGG Pathways 2026 | pathways involving RPEL1 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of RPEL1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of RPEL1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by RPEL1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of RPEL1 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving RPEL1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving RPEL1 protein from the Reactome Pathways 2024 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of RPEL1 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of RPEL1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of RPEL1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of RPEL1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of RPEL1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of RPEL1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with RPEL1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving RPEL1 protein from the Wikipathways Pathways 2014 dataset. | |